Literature DB >> 18282003

Modeling the interactions of herbal drugs to beta-ketoacyl ACP synthase of Mycobacterium tuberculosis H37Rv.

K V Ramesh1, Mitali Purohit, K Mekhala, Mrinalini Krishnan, Kaushiki Wagle, Sudha Deshmukh.   

Abstract

The present paper reports a bio-computational study carried out with the aim of understanding the binding mode of anti-TB herbal ligands onto the homology modeled structure of fatty acid synthase of Mycobacterium tuberculosis (M.tb) H37Rv. Sequence alignment of beta-ketoacyl ACP synthase (KAS) domain of the protein with other related KAS sequences of PDB database revealed high degree of sequence variation. However, the catalytic triad comprising of CHH (cys150-his279-his320) was found to be conserved in the KAS sequence of M.tb H37Rv. The tertiary structure of this protein predicted using genetic algorithm operator in the MODELLER package appeared to give a satisfactory structure for the purpose of studying ligand and substrate binding pockets on the protein. PDB templates complexed with ligands (citric acid and lauric acid) were used for model building. Docking studies carried out with different herbal ligands suggest that, aloe-emodin and nimbin are the best herbal candidates to replace the synthetic drugs 'thiolactomycin/cerulenin'.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18282003     DOI: 10.1080/07391102.2008.10507195

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  2 in total

1.  Aloe Emodin Reduces Phthiodiolone Dimycocerosate Potentiating Vancomycin Susceptibility on Mycobacteria.

Authors:  Céline Rens; Pieter-Jan Ceyssens; Françoise Laval; Philippe Lefèvre; Vanessa Mathys; Mamadou Daffé; Véronique Fontaine
Journal:  Indian J Microbiol       Date:  2018-05-04       Impact factor: 2.461

2.  Designing of inhibitors against drug tolerant Mycobacterium tuberculosis (H37Rv).

Authors:  Deepak Singla; Rupinder Tewari; Ashwani Kumar; Gajendra Ps Raghava
Journal:  Chem Cent J       Date:  2013-03-08       Impact factor: 4.215

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.